[UMC Receives Government Approval to Acquire Stakes in He Jian 1.Date of occurrence of the event:2011/10/31] [FORM 6-K October 31, 2011 United Microelectronics Corporation No. 3 Li Hsin Road II x x n/a United Microelectronics Corporation Chitung Liu Chitung Liu Chief Financial Officer Description 99 6K on 20111031 6-K 1 htm_6230.htm LIVE FILING]
[UMC Receives Government Approval to Acquire Stakes in He Jian 1.Date of occurrence of the event:2011/10/31] [FORM 6-K October 31, 2011 United Microelectronics Corporation No. 3 Li Hsin Road II x x n/a United Microelectronics Corporation Chitung Liu Chitung Liu Chief Financial Officer Description 99 6K on 20111031 6-K 1 htm_6230.htm LIVE FILING]
[Item 4.02. Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review third first regarding its On October 26, 2011, the Audit Committee of China XD Plastics Company Limited (the “Company”) concluded that the Company’s previously filed financial statements for the years ended December 31, 2010 and 2009, for the The Company will be filing]
[Item 4.02. Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review third first regarding its On October 26, 2011, the Audit Committee of China XD Plastics Company Limited (the “Company”) concluded that the Company’s previously filed financial statements for the years ended December 31, 2010 and 2009, for the The Company will be filing]
[______________ FORM 8-K ______________ CURRENT REPORTte of Report (Date of earliest event reported):October 25, 2011 ______________ BIOSTAR PHARMACEUTICALS, ______________ Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer oforporation) Identification No.) No. 588 Shiji Xi Avenue Xianyang City, Shaanxi Province Peoples Republic of China 712046 86-029-33686638 N/A]
[Payment of Filing Fee (Check the appropriate box): x No fee required ¨ Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction applies:_________________________ (2) Aggregate number of securities to which transaction applies:________________________]
[______________ FORM 8-K ______________ CURRENT REPORTte of Report (Date of earliest event reported):October 25, 2011 ______________ BIOSTAR PHARMACEUTICALS, ______________ Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer oforporation) Identification No.) No. 588 Shiji Xi Avenue Xianyang City, Shaanxi Province Peoples Republic of China 712046 86-029-33686638 N/A]
[This Form 6-K consists of: 1. 2. (a joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock Code: 0386) Third Quarter Results Announcement for 2011 §]
[This Form 6-K consists of: THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ACTION If you are in doubt If you have sold or transferred CHINA PETROLEUM & CHEMICAL CORPORATION (a joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock Code: 0386) PROPOSED DOWNWARD ADJUSTMENT TO THE CONVERSION PRICE OF THE A SHARE CONVERTIBLE]
[This Form 6-K consists of: THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ACTION If you are in doubt If you have sold or transferred CHINA PETROLEUM & CHEMICAL CORPORATION (a joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock Code: 0386) PROPOSED DOWNWARD ADJUSTMENT TO THE CONVERSION PRICE OF THE A SHARE CONVERTIBLE]
